As of 2025-07-06, the Intrinsic Value of Tekla Healthcare Opportunities Fund (THQ) is 41.62 USD. This THQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 18.40 USD, the upside of Tekla Healthcare Opportunities Fund is 126.20%.
The range of the Intrinsic Value is 35.71 - 49.85 USD
Based on its market price of 18.40 USD and our intrinsic valuation, Tekla Healthcare Opportunities Fund (THQ) is undervalued by 126.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 35.71 - 49.85 | 41.62 | 126.2% |
| DCF (Growth 10y) | 38.92 - 52.69 | 44.71 | 143.0% |
| DCF (EBITDA 5y) | 77.59 - 99.88 | 87.53 | 375.7% |
| DCF (EBITDA 10y) | 69.06 - 91.58 | 79.04 | 329.6% |
| Fair Value | 114.19 - 114.19 | 114.19 | 520.57% |
| P/E | 24.94 - 39.69 | 27.41 | 49.0% |
| EV/EBITDA | (7.69) - 90.41 | 39.48 | 114.6% |
| EPV | (5.53) - (5.55) | (5.54) | -130.1% |
| DDM - Stable | 28.90 - 52.03 | 40.46 | 119.9% |
| DDM - Multi | 24.05 - 34.37 | 28.34 | 54.0% |
| Market Cap (mil) | 761.39 |
| Beta | 3.55 |
| Outstanding shares (mil) | 41.38 |
| Enterprise Value (mil) | 986.39 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.98% |
| Cost of Debt | 5.00% |
| WACC | 8.54% |